Skip to main content

Newell, Kelly A/Prof

Associate Professor

  • Illawarra Health and Medical Research Institute
  • Centre for Translational Neuroscience
  • Centre for Medical and Molecular Bioscience
  • Faculty of Science, Medicine and Health
  • School of Medicine

Top Publications


Research Overview


  • My research priorities are in molecular psychiatry and neuro-psychopharmacology

    1. I use post-mortem human brain samples to investigate molecular changes that occur in psychiatric disorders, including schizophrenia and depression. I have a particular interest in the glutamatergic neurotransmission system in psychiatric disorders.

    2. I use animal models to investigate molecular changes that occur in the brain throughout normal brain development and how these neurodevelopmental molecular profiles change in animal models of  depression. I have a particular interest in the neurobiology of depression in special populations including pregnancy/postnatal and ageing and understanding the molecular mechanisms of treatments in these populations (including the impact of fetal exposure).

    3. I investigate the effects of current and novel antipsychotic and antidepressant drugs on brain molecules with a particular interest in how exposure to these drugs during the neonatal and adolescent periods, affects continued development of the brain and risk of developing subsequent psychiatric disorders.

    Brief Biography

    • Jan 2018 - : Associate Professor, School of Medicine, UoW
    • Jan 2012 - Dec 2017: Senior Lecturer, School of Medicine, UoW.
    • Dec 2007 – Dec 2011: Lecturer in Neuroscience, School of Health Sciences, UoW
    • 2007: PhD in Neuroscience (supervised by Prof Xu-Feng Huang and Dr Katerina Zavitsanou), School of Health Sciences, UoW.
    • 2006-2007: Short-term teaching contracts, School of Health Sciences, UoW.
    • 2002: Bachelor of Science (Biomedical Science) Honours, School of Health Sciences, UoW. 

Available as Research Supervisor

Selected Publications


Impact Story


Available as Research Supervisor

Advisees


  • Graduate Advising Relationship

    Degree Research Title Advisee
    Doctor of Philosophy Region-Specific Shifts in the Neural Lipid Chemistry of Advanced Huntington’s Disease
    Doctor of Philosophy (Integrated) Glutamatergic and Neurotrophic Signalling in the Pathology and Treatment of Psychiatric Illness. Jarbou, Noor
    Doctor of Philosophy Efficacy Investigation of Terpenes and Cannabidiol in a Rodent Model of Depression Clunas, Helen
    Master of Philosophy -SMAH Post-Exercise Hydrotherapy; Improving Cardiometabolic Health Russell, Brooke
    Doctor of Philosophy An Investigation of the Kynurenine Pathway in Major Depression Brown, Samara

Keywords


  • Animal model
  • Antidepressant
  • Brain development
  • Depression
  • Glutamate neurotransmission
  • Maternal mental health
  • Mental health
  • Neurobiology
  • Neuropharmacology
  • Perinatal
  • Postmortem human brain
  • Pregnancy
  • Psychopharmacology
  • Schizophrenia

Web Of Science Researcher Id


  • K-5550-2014

Top Publications


Research Overview


  • My research priorities are in molecular psychiatry and neuro-psychopharmacology

    1. I use post-mortem human brain samples to investigate molecular changes that occur in psychiatric disorders, including schizophrenia and depression. I have a particular interest in the glutamatergic neurotransmission system in psychiatric disorders.

    2. I use animal models to investigate molecular changes that occur in the brain throughout normal brain development and how these neurodevelopmental molecular profiles change in animal models of  depression. I have a particular interest in the neurobiology of depression in special populations including pregnancy/postnatal and ageing and understanding the molecular mechanisms of treatments in these populations (including the impact of fetal exposure).

    3. I investigate the effects of current and novel antipsychotic and antidepressant drugs on brain molecules with a particular interest in how exposure to these drugs during the neonatal and adolescent periods, affects continued development of the brain and risk of developing subsequent psychiatric disorders.

    Brief Biography

    • Jan 2018 - : Associate Professor, School of Medicine, UoW
    • Jan 2012 - Dec 2017: Senior Lecturer, School of Medicine, UoW.
    • Dec 2007 – Dec 2011: Lecturer in Neuroscience, School of Health Sciences, UoW
    • 2007: PhD in Neuroscience (supervised by Prof Xu-Feng Huang and Dr Katerina Zavitsanou), School of Health Sciences, UoW.
    • 2006-2007: Short-term teaching contracts, School of Health Sciences, UoW.
    • 2002: Bachelor of Science (Biomedical Science) Honours, School of Health Sciences, UoW. 

Selected Publications


Impact Story


Advisees


  • Graduate Advising Relationship

    Degree Research Title Advisee
    Doctor of Philosophy Region-Specific Shifts in the Neural Lipid Chemistry of Advanced Huntington’s Disease
    Doctor of Philosophy (Integrated) Glutamatergic and Neurotrophic Signalling in the Pathology and Treatment of Psychiatric Illness. Jarbou, Noor
    Doctor of Philosophy Efficacy Investigation of Terpenes and Cannabidiol in a Rodent Model of Depression Clunas, Helen
    Master of Philosophy -SMAH Post-Exercise Hydrotherapy; Improving Cardiometabolic Health Russell, Brooke
    Doctor of Philosophy An Investigation of the Kynurenine Pathway in Major Depression Brown, Samara

Keywords


  • Animal model
  • Antidepressant
  • Brain development
  • Depression
  • Glutamate neurotransmission
  • Maternal mental health
  • Mental health
  • Neurobiology
  • Neuropharmacology
  • Perinatal
  • Postmortem human brain
  • Pregnancy
  • Psychopharmacology
  • Schizophrenia

Web Of Science Researcher Id


  • K-5550-2014
uri icon